Waters’ New 1 mm Columns: Where Peak Performance Meets Green Lab Goals
Published: 20 Mar 2026
Author: Precedence Research
Waters Corporation has introduced 1 mm internal diameter liquid chromatography columns featuring MaxPeak Premier Technology. This innovation aims to enhance analytical sensitivity, minimize solvent usage, and improve recovery rates for complex biomolecules in high-throughput pharmaceutical and biopharmaceutical labs.
The 1 mm Revolution: Waters Redefines High-Sensitivity Chromatography
The new 1 mm internal diameter liquid chromatography (LC) columns with MaxPeak Premier Technology are available in Waters' ACQUITY, BioResolve, and GTxResolve product lines. These microflow columns enhance analytical sensitivity while reducing solvent consumption and sample waste, crucial for bioanalysis and pharmaceutical development.
According to Precedence Research, the Chiral Chromatography Columns Market size accounted for USD 123.07 million in 2025 and is predicted to increase from USD 130.85 million in 2026 to approximately USD 227.14 million by 2035, expanding at a CAGR of 6.32% from 2026 to 2035 due to rising demand for enantiopure drugs in pharmaceutical R&D, stringent regulatory mandates for drug safety, and the growth of biopharmaceuticals.
In high-throughput pharmaceutical labs, detecting trace-level compounds in complex biological samples is essential. Waters' 1 mm columns improve sensitivity, reproducibility, and analyte recovery, addressing challenges posed by traditional stainless-steel columns.
Waters’ Elevates Metabolomics and Peptide Analysis with 1 mm HPS Technology
This launch is part of Waters' commitment to chemistry innovation, aimed at enhancing the separation performance of larger, complex molecules. Standard columns can hinder recovery rates for peptides and oligonucleotides due to metal surface interactions, impacting quantitative accuracy at low concentrations.
The 1 mm columns utilize MaxPeak High Performance Surface Technology in a microflow setup to reduce nonspecific adsorption, which can lead to analyte loss and affect quantitative accuracy. This enhancement improves recovery rates for small molecules, peptides, and challenging oligonucleotides. Dr. Oliver Fiehn from UC Davis noted that his team achieved necessary analytical sensitivity after switching from 2.1 mm stainless steel columns to those with MaxPeak Premier Technology. He highlighted that the 1 mm microflow format saves solvents while ensuring consistent results in high-throughput metabolomics. Waters reports that labs transitioning from 2.1 mm to 1 mm columns can achieve similar or improved sensitivity with only a quarter of the solvent and sample volume, potentially reducing costs and promoting sustainability.
A recent report by Precedence Research highlights that the Chiral Chromatography Columns Market is benefiting from robust demand in the pharmaceutical and biotechnology sectors, driven by the need for enantiomerically pure drug formulations, stringent regulatory requirements for drug safety (FDA/EMA), and a growing pipeline of chiral active pharmaceutical ingredients (APIs).